PGEN Chart
- 52-Week Range: $1.15 - $7.33
- Market Capitalization: $259.62M
- Short Percentage: 0%
- Target Price: $12.20
- Shares Outstanding: 207.69M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
PGEN released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Precigen: A Substantially Undervalued And Differentiated Gene Therapy CompanySeeking Alpha | January 10th
- Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer PatientsBenzinga | December 14th
- Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ TherapiesPRNewsWire | November 4th
- Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical DevelopmentsPRNewsWire | October 27th
- Precigen, Inc. (PGEN) CEO Helen Sabzevari on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 9th
- Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9thPRNewsWire | August 2nd
Company Info
Website: https://www.precigen.com
Address: 20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
Sector: Healthcare
Industry: Biotechnology
Full time employees: 456
Address: 20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
Sector: Healthcare
Industry: Biotechnology
Full time employees: 456
$PGEN bag holders for life club
$PGEN Starting a small position
$PGEN who else excited??
$PGEN Buy now
$PGEN just go up
$PGEN we need one good push to moon this.
$PGEN Overpower the algos!
$PGEN God dammit
$PGEN When in doubt...
$PGEN said y’all dumb af